Pfizer CEO Albert Bourla tests COVID positive

Published On 2022-08-16 10:09 GMT   |   Update On 2022-08-16 10:09 GMT
Advertisement

New York: Pfizer Inc Chief Executive Officer Albert Bourla has said that he had tested positive for COVID-19 and was experiencing very mild symptoms.

Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.
Advertisement
Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech.

Read also: Pfizer to purchase Global Blood Therapeutics for USD 5.4 Billion




Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News